The drug maker's bullish earnings forecast should result in continued healthy gains.

Early today, Eli Lilly (ticker: LLY) said it expects adjusted earnings of $3.75 to $3.90 a share on revenue of $22.6 billion to $23.4 billion in 2013, ahead of analysts' forecasts for earnings of $3.71 a share on...